Options for Lowering the Threshold to Brussels Out-of-hours Primary Care Services for Dutch Speaking Citizens (BruWNed)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Previous studies have shown that language barriers in healthcare can lead to communication problems between healthcare provider and patient. This can lead to a decrease in satisfaction, quality of care and patient safety. Dutch speakers are a minority in Brussels (a Dutch-French bilingual region in Belgium), and the majority of general practitioners (GPs) in the Brussels out-of-hours primary care services are French-speaking. Measures are already being taken to increase the number of bilingual (Dutch and French) GPs.
In addition, several technological tools (e.g. video interpreting, translation apps, ...) exist to overcome language barriers. The investigators want to explore which of these options can be used in Brussels out-of-hours primary care services to improve access for Dutch-speaking citizens. The objective of this study is to examine both barriers and facilitators to use these technological translation tools during language-discordant consultations with a French-speaking GP and a Dutch-speaking patient in Brussels out-of-hours primary care services.
To achieve this objective, the investigators aim to engage Dutch-speaking patients, Dutch- and/or French-speaking GPs, as well as Dutch- and/or French-speaking representatives from pertinent organizational and policy sectors.
There will be about 40 participants in total. Participants will answer questions during an online group session (focus group). There will be 4 focus groups, with a maximum of 10 participants in each focus group. Each focus group will last 60-90 minutes.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Aurore Torsin
- Phone Number: +32 2 477 41 02
- Email: aurore.torsin@vub.be
Study Contact Backup
- Name: Prof. Dr. A. Roex
- Email: ann.roex@vub.be
Study Locations
-
-
Brussels
-
Jette, Brussels, Belgium, 1090
- Recruiting
- Vrije Universiteit Brussel
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients: adult, living in Brussels, Dutch-speaking
- GPs: adult, working in Brussels, Dutch- and/or French-speaking
- Employees of professional organization-regulatory bodies: adult, Dutch-and/or French-speaking
Exclusion Criteria:
- Subject is not capable of will
- Subject cannot express themself in Dutch or French
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Focus Group
Four groups of participants will meet for online focus groups, identifying barriers and facilitators to the use of technological translation tools in Brussels out-of-hours primary care services for Dutch-speaking patients and French-speaking general practitioners.
|
Dutch-speaking patients, Dutch- and/or French-speaking general practitioners and Dutch- and/or French-speaking representatives from pertinent organizational and policy sectors will be questioned in heterogeneous focus groups, identifying barriers and facilitators to the use of technological translation tools in Brussels out-of-hours primary care services for Dutch-speaking patients and French-speaking general practitioners.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Exploration of barriers and facilitators of different stakeholders to the use of technological translation tools in Brussels out-of-hours primary care services for Dutch-speaking patients and French-speaking general practitioners.
Time Frame: The outcome will be measured during the online focus group, which will have a duration of 60 to 90 minutes.
|
Focus group results will provide a list of barriers and facilitators to the use of technological translation tools in Brussels out-of-hours primary care services for Dutch-speaking patients and French-speaking general practitioners.
|
The outcome will be measured during the online focus group, which will have a duration of 60 to 90 minutes.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Prof. Dr. A. Roex, Vrije Universiteit Brussel
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 24366_BruWNed
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.